MDBH MDB CAPITAL HOLDINGS LLC

MDB Capital Holdings Provides Second Quarter 2025 Update

MDB Capital Holdings Provides Second Quarter 2025 Update

Management to Host Conference Call Today at 4:30 p.m. ET

Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025, and subsequent developments.

Second Quarter 2025 and Subsequent Operational Highlights

  • Launched private offering for Paulex Bio, a company developing a transformational oral medication designed to eliminate the root cause of diabetes.
  • Announced our next IPO and filed S-1 for Buda Juice, which is redefining the fresh juice category with UltraFresh™ cold-crafted juices.
  • Deepened our pipeline of early-stage, disruptive companies capable of becoming leaders in new categories.
  • Announced new strategic partnership with Keiretsu Forum MST to drive IPO Angels, a platform that will further expand MDB’s investor community.
  • Broadened relationships with RIAs to reach new investors with large equity portfolios looking for new strategies to gain venture exposure.
  • Announced plans to spin-out PatentVest, the “next generation” IP law firm, as an independent public company in 2026 to further leverage this unique asset and create value for MDB.

“We’re betting that the public markets are the place to be for emerging companies as the traditional venture and private equity markets are under significant restructuring,” said Christopher Marlett, CEO and Co-Founder of MDB Capital Holdings. “We’re excited to launch more visionary companies on public markets and provide investors with additional public venture opportunities.”

Second Quarter 2025 Update Zoom Webinar at 4:30 p.m. ET Today

Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, and anticipated milestones, as well as host a question-and-answer session.

Investors can pre-register now for the Zoom webinar . The live webinar will also be accessible  on the day of the event through MDB’s investor relations website at .

About MDB Capital Holdings, LLC

Founded in 1997, MDB Capital focuses on launching "Big Ideas" into valuable public companies with a better approach to public venture capital. This approach leverages community-driven financings of early-stage emerging leaders in meaningful business and technology categories via early public offerings, primarily listed on NASDAQ, as well as post-IPO offerings for companies that align with MDB's overall investment criteria.

MDB Capital is the brand under which MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries operate. Its subsidiaries includes MDB Capital, a venture-focused broker-dealer with MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm dedicated to transforming innovation into market value. MDB Capital is a registered broker-dealer, Member FINRA/SIPC.

For more information, please visit .

Forward-Looking Statements

This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements.

Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.

Investor Relations Contact:



Media Contact:





EN
27/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MDB CAPITAL HOLDINGS LLC

 PRESS RELEASE

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Le...

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining disruptive technology companies, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025. More Detailed Information 2025 Annual Shareholder Letter . Form 10-K . Key Assets and Strategic Developments eXoZymes (NASDAQ: EXOZ): MDB holds appr...

 PRESS RELEASE

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Ra...

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.” The report provides a comprehensive analysis of the rapidly evolving amylin drug landscape, a mechanism once considered commercially unviable that is now at the center of global pharmaceutical strategy. Over the past eighteen months, more than $19 billion i...

 PRESS RELEASE

PatentVest Highlights New Legal Article on AI Patenting Strategy by Se...

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries. The IP Legal Insights section serves as a resource for founders, executives, and investors seeking to better understand how intellectual property decisions impact innovation, competitive positioning...

 PRESS RELEASE

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stak...

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services IP Strategy and Legal firm backs vascular technology innovator with both expertise and capital commitment Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest, a leading provider of IP Strategy and Legal services, today announced a strategic engagement with Life Seal Vascular and disclosed that it has accepted equity in the company as partial consideration for its services. The arrangement reflects PatentVest's conviction in Life Seal Vascular's underlying technology and...

 PRESS RELEASE

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results...

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founde...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch